Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial
Abstract Background Wound management is a critical factor when treating patients with the inherited skin fragility disease dystrophic epidermolysis bullosa (DEB). Due to genetic defects in structural proteins, skin and mucous epithelia are prone to blistering and chronic wounding upon minor trauma....
Guardado en:
Autores principales: | Christina Guttmann-Gruber, Josefina Piñón Hofbauer, Birgit Tockner, Victoria Reichl, Alfred Klausegger, Peter Hofbauer, Martin Wolkersdorfer, Khek-Chian Tham, Seong Soo Lim, John E. Common, Anja Diem, Katharina Ude-Schoder, Wolfgang Hitzl, Florian Lagler, Julia Reichelt, Johann W. Bauer, Roland Lang, Martin Laimer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97b40c2da2df4214a64bb591a0e70e81 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
por: Franciscus C. Vermeer, et al.
Publicado: (2021) -
Digenic Mutations in Junctional Epidermolysis Bullosa in An Iranian Family
por: Kourosh Riahi, et al.
Publicado: (2021) -
Kidney and Urinary Tract Involvement in Epidermolysis Bullosa: Is Routine Follow-Up Necessary?
por: Neslihan Cicek, et al.
Publicado: (2021) -
Mitrofanoff continent vesicostomy as a treatment option for epidermolysis bullosa complicated by posterior urethral stenosis
por: A. Kissel, et al.
Publicado: (2022) -
Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
por: Nadezhda A. Evtushenko, et al.
Publicado: (2021)